Punch & Associates Investment Management’s Journey Medical DERM Stock Holding History

Punch & Associates Investment Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.79M	Buy	+536,000	New	+$3.06M	0.19%	117

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return

Trexquant Investment Stamford, Connecticut $17B AUM 39.66% 1-Year Est. Return

Punch & Associates Investment Management's DERM Position: Q2 2026 in Review

Punch & Associates Investment Management opened a new position in Journey Medical (DERM) in Q2 2026: 536,000 shares worth $3.79M. The stake represents 0.19% of the portfolio and ranks #117 among its holdings.

62 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Punch & Associates Investment Management held 536,000 shares of Journey Medical worth $3.79M as of Q2 2026.
Journey Medical was a new Punch & Associates Investment Management position in Q2 2026.
Journey Medical made up 0.19% of Punch & Associates Investment Management's portfolio in Q2 2026, its #117 holding.
62 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Punch & Associates Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.